GOP senators urge FDA to reconsider approval of generic abortion pill

In a significant political move, nearly all GOP senators have called on the FDA to reconsider its approval of a generic version of the abortion pill mifepristone. This push reflects ongoing tensions surrounding reproductive rights and could impact access to abortion services across the country. The senators' request highlights the contentious nature of the abortion debate in the U.S., as they seek to challenge a decision that many believe could affect women's health choices.